Publication: 179

Phase III Trial of Bevacizumab Plus Interferon Alfa Versus Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: Final Results of CALGB 90206
      QxMD      Google Scholar   
Citation:
J Clin Oncol vol 28 (13) 2137-43
Year:
2010
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
497   698  
Children:
None
Program:
OGC
Primary Committee:
GU
Sec. Committees:
   
Pharmas:
 
Grants:
CA14985, CA33601, CA41287, U10 CA077202, U10 CA045808, U10 CA031946, U10 CA033601, CA60138, CA45808, U10 CA077440, CA77440, U10 CA041287, CA77202, CA47642, U10 CA047642, CA31946  
Corr. Author:
 
Authors:
                       
Networks:
 
Study
CALGB-90206
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
Guc19, Original Reports, Genitourinary Cancer